FLT3-ITD is the most relevant FLT3 aberration in AML as it confers poor prognosis when associated with NPM1c mutation [8, 22, 23] and is mutated in 45.7% of NK AML cases [24]. This evidence concerns the gene FLT3 and acute myeloid leukemia.